文献速递胸部CTMRPET

肺癌非手术治疗后的影像随访:AJR专家小组叙述性综述

Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review.
PubMed 文献 · AJR Am J Roentgenol · 2023-04-05

本文为AJR专家小组叙述性综述,阐述肺癌非手术治疗的现状及治疗后随访中可见的预期与意外影像表现。覆盖全身治疗(传统化疗、靶向治疗、免疫治疗)、放疗和热消融,目标是指导放射科医生对此类治疗后的影像评估,主要聚焦非小细胞肺癌。

要点

  • 熟悉免疫治疗、靶向治疗、放疗和热消融后的预期影像改变,避免将治疗相关改变误判为进展。
  • 识别治疗后并发症与复发肿瘤的影像表现,是随访评估的关键。
  • 综述聚焦非小细胞肺癌,多数患者因合并症或晚期诊断而未接受手术切除。

核心结论

  • 综述旨在为放射科医生提供肺癌非手术治疗后影像评估的指导,帮助区分治疗后改变、治疗并发症与复发肿瘤。
  • 非手术治疗持续演进,全身与靶向治疗种类增多,随访影像表现也随之变化。

研究设计与样本

  • 本文为AJR专家小组叙述性综述,非系统检索研究,未报告样本量、中心数或参考标准。
  • 覆盖的治疗包括全身治疗(传统化疗、靶向治疗、免疫治疗)、放疗和热消融,主要聚焦非小细胞肺癌。

关键影像表现/征象

  • 综述描述了非手术治疗后随访中可见的预期与意外影像表现,涉及治疗后改变、治疗并发症和复发肿瘤。
  • 原文未报告具体影像征象、信号或密度特点。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、阈值或分级标准。

临床应用与阅片要点

  • 阅片时应结合治疗类型(化疗、靶向、免疫、放疗或热消融)解读随访影像,注意区分治疗相关改变与肿瘤进展。
  • 报告需关注治疗并发症与复发肿瘤的征象,避免将预期治疗改变误报为复发。
  • 综述主要针对非小细胞肺癌,其他病理类型的随访评估需谨慎外推。

局限性

  • 本文为专家小组叙述性综述,非系统评价,未报告检索策略、纳入标准或证据分级。
  • 原文未报告具体研究数据或验证性结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Lung cancer continues to be the most common cause of cancer-related death worldwide. In the past decade, with the implementation of lung cancer screening programs and advances in surgical and nonsurgical therapies, the survival of patients with lung cancer has increased, as has the number of imaging studies that these patients undergo. However, most patients with lung cancer do not undergo surgical re-section, because they have comorbid disease or lung cancer in an advanced stage at diagnosis. Nonsurgical therapies have continued to evolve with a growing range of systemic and targeted therapies, and there has been an associated evolution in the imaging findings encountered at follow-up examinations after such therapies (e.g., with respect to posttreatment changes, treatment complications, and recurrent tumor). This AJR Expert Panel Narrative Review describes the current status of nonsurgical therapies for lung cancer and their expected and unexpected imaging manifestations. The goal is to provide guidance to radiologists regarding imaging assessment after such therapies, focusing mainly on non-small cell lung cancer. Covered therapies include systemic therapy (conventional chemotherapy, targeted therapy, and immunotherapy), radiotherapy, and thermal ablation.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Murphy, Mayoral, Larici, et al. Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023. PMID: 37095669. doi:10.2214/AJR.23.29104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。